These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9085318)

  • 1. A pharmacist-initiated program of intravenous to oral antibiotic conversion.
    Przybylski KG; Rybak MJ; Martin PR; Weingarten CM; Zaran FK; Stevenson JG; Levine DP
    Pharmacotherapy; 1997; 17(2):271-6. PubMed ID: 9085318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.
    Bailey TC; Ritchie DJ; McMullin ST; Kahn M; Reichley RM; Casabar E; Shannon W; Dunagan WC
    Pharmacotherapy; 1997; 17(2):277-81. PubMed ID: 9085319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS; Sorensen SV; Liu LZ; Itani KM
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: a pharmacoeconomic analysis.
    Amodio-Groton M; Madu A; Madu CN; Briceland LL; Seligman M; McMaster P; Miller MH
    Ann Pharmacother; 1996 Jun; 30(6):596-602. PubMed ID: 8792944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streamlining antimicrobial therapy through pharmacists' review of order sheets.
    Briceland LL; Lesar TS; Lomaestro BM; Lombardi TP; Gailey RA; Kowalsky SF
    Am J Hosp Pharm; 1989 Jul; 46(7):1376-80. PubMed ID: 2757043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pharmaceutical counselling on antimicrobial use in surgical wards: intervention study with historical control group.
    Grill E; Weber A; Lohmann S; Vetter-Kerkhoff C; Strobl R; Jauch KW
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):739-46. PubMed ID: 21452339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
    Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
    Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK; Nopmaneejumruslers C; Chan CK
    Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the cost-effectiveness of sequential antibiotic (ciprofloxacin) therapy].
    Ludwig E; Kovács G; Nagy G; Székely E
    Orv Hetil; 1997 Nov; 138(48):3043-7. PubMed ID: 9441266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumonia.
    Davis SL; Delgado G; McKinnon PS
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S136-43. PubMed ID: 15942880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A prospective comparative study to assess the impact of pharmaceutical intervention in the promotion of sequential therapy with flouroquinolones].
    Pinteño Blanco M; Delgado Sánchez O; Escrivá Torralva A; Crespí Monjo M; Ventayol Bosch P; Puigventós Latorre F; Martínez López I
    Farm Hosp; 2004; 28(6):419-25. PubMed ID: 15628944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral.
    Kuti JL; Le TN; Nightingale CH; Nicolau DP; Quintiliani R
    Am J Health Syst Pharm; 2002 Nov; 59(22):2209-15. PubMed ID: 12455304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a pharmacy resident on hospital length of stay and drug-related costs.
    Terceros Y; Chahine-Chakhtoura C; Malinowski JE; Rickley WF
    Ann Pharmacother; 2007 May; 41(5):742-8. PubMed ID: 17440008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist intervention program focused on i.v. ranitidine therapy.
    Santora J; Kitrenos JG; Green ER
    Am J Hosp Pharm; 1990 Jun; 47(6):1346-9. PubMed ID: 2368729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria-based antimicrobial i.v. to oral conversion program.
    Okpara AU; Maswoswe JJ; Stewart K
    Formulary; 1995 Jun; 30(6):343-8. PubMed ID: 10144873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Economic impact of pharmacist's interventions: illustration in a rheumatology ward].
    Coursier S; Bontemps H; Brantus JF; Allenet B
    J Pharm Belg; 2008 Dec; 63(4):103-9. PubMed ID: 19320133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.